PHARMAIDS PHARMACEUTICALS LTD. Share Price

₹ 21.26

+₹0.73 (3.56%)
1D
Last updated 20 Nov, 2026, 15:29 IST
BSE: 524572
|
Pharmaceuticals

PHARMAIDS PHARMACEUTICALS LTD. Share Price Today

As of 23 Nov 2026, PHARMAIDS PHARMACEUTICALS LTD. share price is ₹21.26. The stock opened at ₹20.49, compared to its previous close of ₹20.53. During today's trading session, PHARMAIDS PHARMACEUTICALS LTD. share price moved in the range of ₹19.90 to ₹21.90, with an average price of ₹20.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹19.90 and a high of ₹53.90.

Share price over the last 1 day rose from 19.90 to 21.26, ranging between 19.90 and 21.90.

₹19.90
3.56% up today
₹21.90
1D LOW
1D HIGH

PHARMAIDS PHARMACEUTICALS LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 5.67% YoY
Latest Earning
Net Profit TrendUp by 14.36% YoY
Latest Earning
Revenue TrendUp by 5.52% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 56.16 % in last 1 yr
PHARMAIDS PHARMACEUTICALS LTD. stock performance
Open₹20.49
High₹21.90
Low₹19.90
Prev. close₹20.53
PHARMAIDS PHARMACEUTICALS LTD. trading activity
Volume18,768
Average traded price₹20.87
Last traded time03:29:03 20 Nov
Last traded quantity451

Circuit
L
H
₹19.50
₹23.82
52-week
L
H
₹19.90
₹53.90
Mkt Cap Cr
76.39

P/E
-20.83

P/B
1.6

ROA
-4.18%
ROE
-15.38%

ROCE
-8.43%

Quick Ratio
0.44

EV/EBITDA
-116.82

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Pharmaids Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Pharmaids Pharma appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Pharmaids Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.67
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.03
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.58
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.59
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.48
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

PHARMAIDS PHARMACEUTICALS LTD. Company Background

ISIN
INE117D01018
Sector Market Cap
₹ 76.39 Cr

Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.

PHARMAIDS PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹28.17 crore in FY26 vs ₹19.55 crore in FY25. It showed an increase of 44.09% on a yearly basis.
  • Operating Profit: PHARMAIDS PHARMACEUTICALS LTD. reported an operating loss of ₹16.30 crore in FY26 vs ₹17.28 crore in FY25. It showed an increase of 5.67% on a year-on-year basis.
  • Net Profit: PHARMAIDS PHARMACEUTICALS LTD. reported a net loss of ₹11.57 crore in FY26 vs ₹13.51 crore in FY25. It showed an increase of 14.36% on a yearly basis.

PHARMAIDS PHARMACEUTICALS LTD. Quarterly Result Highlights

  • PHARMAIDS PHARMACEUTICALS LTD. reported revenue of ₹4.40 crore in Sep 2026, compared with ₹4.17 crore in Jun 2026, representing an increase of 5.52% on a quarter-on-quarter (QoQ) basis.
  • PHARMAIDS PHARMACEUTICALS LTD. reported an operating loss of ₹2.37 crore in Sep 2026, compared with ₹2.41 crore in Jun 2026, representing a decrease of 198.34% on a quarter-on-quarter (QoQ) basis.
  • PHARMAIDS PHARMACEUTICALS LTD. reported a loss of ₹1.81 crore in Sep 2026, compared with ₹1.87 crore in Jun 2026, reflecting a decrease of 196.79% on a QoQ basis.
  • The earnings per share (EPS) of PHARMAIDS PHARMACEUTICALS LTD. stood at ₹3.31 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
32.99%
FII
0.00%
Other DII
0.00%
Retail and other
67.01%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

PHARMAIDS PHARMACEUTICALS LTD. Investment Returns

1 day
+5.50%

1 week
-24.00%

1 month
-30.73%

1 year
-53.58%

3 years
-44.74%

5 years
+36.23%

PHARMAIDS PHARMACEUTICALS LTD. Share Price History

PHARMAIDS PHARMACEUTICALS LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹20.49 / ₹21.66
+5.50%
19 Nov 26
₹25.50 / ₹20.53
-18.63%
18 Nov 26
₹27.85 / ₹25.23
-6.62%
17 Nov 26
₹29.90 / ₹27.02
-3.74%
Show more

PHARMAIDS PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹27.88₹19.45₹15.11₹0.00
Other Income₹0.29₹0.10₹0.88₹0.00
Total Revenue₹28.17₹19.55₹15.99₹0.00
Total Expenses₹46.94₹36.73₹30.79₹9.91
Profit Before Tax-₹16.30-₹17.28-₹15.62-₹9.91
Tax-₹4.73-₹3.77-₹3.78-₹2.35
Profit After Tax-₹11.57-₹13.51-₹11.84-₹7.56
EPS - Basic-₹3.31-₹3.05-₹3.56-₹5.86
EPS - Diluted-₹3.31-₹3.05-₹3.56-₹5.86

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹16.30-₹17.28-₹15.62-₹9.91
Income before WC changes-₹14.03-₹12.47-₹11.74-₹9.86
Change in Assets₹10.37-₹17.54₹0.55₹6.15
Change in Liabilities-₹0.39₹14.96₹0.57-₹0.31
Change in WC₹9.97-₹2.58₹1.12₹5.84
Cash flow from Operations-₹4.06-₹15.11-₹10.62-₹4.02
Cash flow from Investing₹23.34-₹12.22-₹74.99-₹4.94
Cash flow from Financing-₹19.97₹23.36₹77.66₹21.31
Total Cash Flow-₹0.69-₹3.98-₹7.95₹12.35
Cash (Start of the year)₹0.82₹4.80₹12.75₹0.41
Cash (End of the year)₹0.13₹0.82₹4.80₹12.75

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹76.27₹98.87₹77.81₹7.07
Current Assets₹10.99₹20.99₹13.53₹17.51
Total Assets₹87.26₹119.85₹91.34₹24.59
Current Liabilities₹24.01₹28.71₹11.58₹2.13
Net Current Asset-₹13.02-₹7.73₹1.96₹15.39
Non-Current Liabilities₹15.65₹36.10₹9.27₹0.00
Equity Capital₹47.60₹55.04₹70.50₹22.46
Total Equity & Liabilities₹87.26₹119.85₹91.34₹24.59

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10.60₹2.34₹0.03₹0.00
Other Income₹0.66₹1.02₹0.80₹0.00
Total Revenue₹11.26₹3.36₹0.82₹0.00
Total Expenses₹28.33₹11.95₹6.91₹9.91
Profit Before Tax-₹13.95-₹8.59-₹6.09-₹9.91
Tax-₹3.52-₹1.31-₹1.14-₹2.35
Profit After Tax-₹10.44-₹7.28-₹4.95-₹7.56
EPS - Basic-₹2.95-₹2.06-₹2.18-₹5.86
EPS - Diluted-₹2.95-₹2.06-₹2.18-₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹13.95-₹8.59-₹6.09-₹9.91
Income before WC changes-₹14.01-₹6.62-₹3.44-₹9.86
Change in Assets₹9.59-₹15.16₹1.33₹6.16
Change in Liabilities₹0.88₹14.05-₹1.33-₹0.32
Change in WC₹10.48-₹1.11₹0.00₹5.84
Cash flow from Operations-₹3.53-₹7.72-₹3.44-₹4.02
Cash flow from Investing₹24.53-₹18.90-₹72.51-₹4.94
Cash flow from Financing-₹21.36₹24.64₹65.66₹21.31
Total Cash Flow-₹0.36-₹1.99-₹10.29₹12.35
Cash (Start of the year)₹0.47₹2.46₹12.75₹0.41
Cash (End of the year)₹0.11₹0.47₹2.46₹12.75

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹78.14₹102.04₹80.24₹6.27
Current Assets₹5.82₹12.68₹4.76₹18.28
Total Assets₹83.96₹114.72₹85.00₹24.55
Current Liabilities₹15.64₹15.23₹1.10₹2.12
Net Current Asset-₹9.82-₹2.55₹3.66₹16.16
Non-Current Liabilities₹14.94₹35.70₹12.84₹0.00
Equity Capital₹53.38₹63.79₹71.06₹22.43
Total Equity & Liabilities₹83.96₹114.72₹85.00₹24.55
* All values are in INR Crore
PHARMAIDS PHARMACEUTICALS LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
PHARMAIDS PHARMACEUTICALS LTD. technical summary
Bearish indicators3
Neutral indicators1
Bullish indicators4
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
27.69
Bearish

ATR (14)
2.43
Neutral

STOCH(9,6)
15.17
Bullish

STOCH RSI (14)
18.6
Bullish

ADX(9)
34.93
Bearish

UO(9)
25.89
Bullish

ROC(12)
-26.15
Bearish

WillR(14)
-84.83
Bullish
Period
Simple value
Exponential vaue

5D
24.5
23.88

10D
27
25.72

20D
27.71
27.19

50D
29.07
28.83

100D
30.85
29.95
Volume trend — traded volume by day
20 Nov0L
19 Nov0L
18 Nov0L
17 Nov0L
16 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

PHARMAIDS PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

PHARMAIDS PHARMACEUTICALS LTD. Returns Calculator

PHARMAIDS PHARMACEUTICALS LTD. Share Price FAQs












Please be aware that PHARMAIDS PHARMACEUTICALS LTD. stock prices are subject to continuous fluctuations due to various factors.